NCT07500272

Brief Summary

This study aim to evaluate the agreement of ocular biometric parameters and intraocular lens between two devices (OA-2000 and Pentacam AXL) in patients with cataract. Participants will be measured ocular biometric parameters once with each device in a random order by the same experienced operator.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
94

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 2, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 29, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 29, 2024

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

March 18, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 30, 2026

Completed
Last Updated

March 30, 2026

Status Verified

March 1, 2026

Enrollment Period

3 months

First QC Date

March 18, 2026

Last Update Submit

March 24, 2026

Conditions

Keywords

biometrykeratometryaxial lenghtintraocular lenscataract

Outcome Measures

Primary Outcomes (1)

  • Agreement of Intraocual lens power between OA-2000 and Pentacam AXL in cataract patients

    Intraocular lens power calculated using SRK/T, Barrett Universal II, and Hoffer Q formulas in diopters

    Immediately after participating in the study

Secondary Outcomes (9)

  • Agreement of flat keratometery(K1) between OA-2000 and Pentacam AXL in cataract patients

    Immediately after participating in the study

  • Agreement of steep keratometry(K2) between OA-2000 and Pentacam AXL in cataract patient

    Immediately after participating in the study

  • Agreement of mean keratometry(Km) between OA-2000 and Pentacam AXL in cataract patient

    Immediately after participating in the study

  • Agreement of anterior chamber depth (ACD) between OA-2000 and Pentacam AXL in cataract patients

    Immediately after participating in the study

  • Agreement of white-to-white distance (WTW) between OA-2000 and Pentacam AXL in cataract patients

    Immediately after participating in the study

  • +4 more secondary outcomes

Study Arms (1)

Cataract patients

Patients with cataract who were scheduled for cataract surgery

Device: Swept-source optical coherence tomography with Placido-disc topographyDevice: Scheimpflug tomography with partial coherence interferometry

Interventions

Measurement technology using swept-source optical coherence tomography with Placido-disc topography

Also known as: OA-2000
Cataract patients

Measurement technology using Scheimpflug tomography with partial coherence interferometry

Also known as: Pentacam AXL
Cataract patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants diagnosed with cataracts and scheduled for cataract surgery at the Ophthalmology Outpatient Department, Burapha University Hospital, Chonburi, Thailand

You may qualify if:

  • Participants aged 18 years or older, diagnosed with cataracts and scheduled for cataract surgery

You may not qualify if:

  • History of corneal trauma
  • Prior ocular surgery
  • The use of contact lenses within two weeks of measurement
  • The presence of other concurrent ocular pathologies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Burapha University

Chon Buri, 20131, Thailand

Location

Related Publications (5)

  • Hua Y, Qiu W, Xiao Q, Wu Q. Precision (repeatability and reproducibility) of ocular parameters obtained by the Tomey OA-2000 biometer compared to the IOLMaster in healthy eyes. PLoS One. 2018 Feb 27;13(2):e0193023. doi: 10.1371/journal.pone.0193023. eCollection 2018.

    PMID: 29486009BACKGROUND
  • Wang W, Miao Y, Savini G, McAlinden C, Chen H, Hu Q, Wang Q, Huang J. Precision of a new ocular biometer in eyes with cataract using swept source optical coherence tomography combined with Placido-disk corneal topography. Sci Rep. 2017 Oct 23;7(1):13736. doi: 10.1038/s41598-017-13800-7.

    PMID: 29061989BACKGROUND
  • Asawaworarit R, Satitpitakul V, Taweekitikul P, Pongpirul K. Agreement of total corneal power between 2 swept-source optical coherence tomography and Scheimpflug tomography in normal and keratoconic patients. PLoS One. 2022 May 24;17(5):e0268856. doi: 10.1371/journal.pone.0268856. eCollection 2022.

    PMID: 35609043BACKGROUND
  • Ruiz-Mesa R, Abengozar-Vela A, Ruiz-Santos M. Comparison of a new Scheimpflug imaging combined with partial coherence interferometry biometer and a low-coherence reflectometry biometer. J Cataract Refract Surg. 2017 Nov;43(11):1406-1412. doi: 10.1016/j.jcrs.2017.08.016.

    PMID: 29223229BACKGROUND
  • Guimaraes de Souza R, Montes de Oca I, Esquenazi I, Al-Mohtaseb Z, Weikert MP. Updates in Biometry. Int Ophthalmol Clin. 2017 Summer;57(3):115-124. doi: 10.1097/IIO.0000000000000175. No abstract available.

    PMID: 28590285BACKGROUND

MeSH Terms

Conditions

Cataract

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Study Officials

  • Rosepon Asawaworarit, M.D., M.Sc.

    Burapha University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

March 18, 2026

First Posted

March 30, 2026

Study Start

September 2, 2024

Primary Completion

November 29, 2024

Study Completion

November 29, 2024

Last Updated

March 30, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

IPD used in the results publication

Shared Documents
STUDY PROTOCOL
Time Frame
IPD and supporting information will be available one year after publicaiton and for two years period.
Access Criteria
Direct contact to corresponding author

Locations